Overview
LLY market data
Price History
LLY price chart
Valuation & Profitability
- P/E (TTM)
- 42.17 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $22.95 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.46 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 0.6% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 33.5% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $629.40 – $1,249.45 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.1T · P/B 38.29 · P/S 14.14.
Company News
Russell 2000 Extends Records, SanDisk Rallies 7%: Stock Market TodayBenzinga · Aug 14, 2026, 5:22 PM
Eli Lilly Just Scored Europe's First Weight Loss Pill Approval -- and the Growth Story Keeps Getting BiggerThe Motley Fool · Aug 14, 2026, 3:46 PM
Fidelity Healthcare ETF vs. iShares Pharma Fund: Which Wins?The Motley Fool · Aug 14, 2026, 2:01 PM
Simplify's PINK or iShares' IYH: Which Healthcare ETF Should Long-Term Investors Choose Right Now?The Motley Fool · Aug 13, 2026, 8:45 PM
Watching Eli Lilly; Hearing Investor Business Daily SwingTrader Sells StockBenzinga · Aug 13, 2026, 2:11 PM
Vinod Khosla Says AI Is Creating a ‘Hyperabundance’ of New Drugs, but Testing Is Still ‘18th-Century’Benzinga · Aug 13, 2026, 8:33 AM
Eli Lilly Escalates Retatrutide Fight, Reports 200-Plus Illegal Sellers to AuthoritiesBenzinga · Aug 12, 2026, 3:34 PM
Watching Eli Lilly; Hearing Investor Business Daily SwingTrader Buys StockBenzinga · Aug 12, 2026, 3:31 PM
Eli Lilly Filed Six New Lawsuits Against U.S. Entities Selling Black-Market RetatrutideBenzinga · Aug 12, 2026, 9:37 AM
Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a ProblemThe Motley Fool · Aug 7, 2026, 11:15 PM